These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23284732)

  • 1. Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.
    Kriegl L; Jung A; Horst D; Rizzani A; Jackstadt R; Hermeking H; Gallmeier E; Gerbes AL; Kirchner T; Göke B; De Toni EN
    PLoS One; 2012; 7(12):e51654. PubMed ID: 23284732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer.
    Nash GM; Gimbel M; Cohen AM; Zeng ZS; Ndubuisi MI; Nathanson DR; Ott J; Barany F; Paty PB
    Ann Surg Oncol; 2010 Feb; 17(2):416-24. PubMed ID: 19813061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
    Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas.
    García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D D; Pagán-Gómez I; Rodríguez-Braun E; Pérez-Guillermo M
    Int J Cancer; 2012 Oct; 131(8):1790-9. PubMed ID: 22287190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India.
    Raman R; Kotapalli V; Adduri R; Gowrishankar S; Bashyam L; Chaudhary A; Vamsy M; Patnaik S; Srinivasulu M; Sastry R; Rao S; Vasala A; Kalidindi N; Pollack J; Murthy S; Bashyam M
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E181-6. PubMed ID: 23168910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
    Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
    Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
    Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
    PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
    Schweiger T; Hegedüs B; Nikolowsky C; Hegedüs Z; Szirtes I; Mair R; Birner P; Döme B; Lang G; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Ann Surg Oncol; 2014 Mar; 21(3):946-54. PubMed ID: 24281417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characteristics of mitochondrial DNA was associated with colorectal carcinogenesis and its prognosis.
    Lee JH; Hwang I; Kang YN; Choi IJ; Kim DK
    PLoS One; 2015; 10(3):e0118612. PubMed ID: 25734426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
    Gallmeier E; Bader DC; Kriegl L; Berezowska S; Seeliger H; Göke B; Kirchner T; Bruns C; De Toni EN
    PLoS One; 2013; 8(2):e56760. PubMed ID: 23460812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive expression analysis of TNF-related apoptosis-inducing ligand and its receptors in colorectal cancer: Correlation with MAPK alterations and clinicopathological associations.
    Tsikalakis S; Chatziandreou I; Michalopoulos NV; Theodoropoulos GE; Sakellariou S; Korkolopoulou P; Patsouris E; Saetta AA
    Pathol Res Pract; 2018 Jun; 214(6):826-834. PubMed ID: 29731264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
    Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
    Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant allele-specific imbalance modulates prognostic impact of KRAS mutations in colorectal adenocarcinoma and is associated with worse overall survival.
    Hartman DJ; Davison JM; Foxwell TJ; Nikiforova MN; Chiosea SI
    Int J Cancer; 2012 Oct; 131(8):1810-7. PubMed ID: 22290300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
    Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
    Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.
    Sameer AS; Chowdri NA; Syeed N; Banday MZ; Shah ZA; Siddiqi MA
    BMC Cancer; 2010 Jun; 10():300. PubMed ID: 20565773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Evidence on the Interaction Between MLK4, KRAS and Microsatellite Instability to Determine the Prognosis of Early-Stage Colorectal Carcinoma.
    Brandl L; Horst D; Grünewald TGP; Mayerle J; Sendelhofert A; Neumann J; Kirchner T; De Toni EN
    Cell Physiol Biochem; 2019; 53(5):820-831. PubMed ID: 31701729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.